Drug & intervention

furosemide

RxCUI 4603

Clinical trials55
Recruiting2
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Furosemide

Furosemide, sold under the brand name Lasix among others, is a loop diuretic medication used to treat edema due to heart failure, liver scarring, or kidney disease. Furosemide may also be used for the treatment of high blood pressure. It can be taken intravenously or orally. When given intravenously, furosemide typically takes effect within five minutes; when taken orally, it typically metabolizes within an hour. Common side effects include orthostatic hypotension (decrease in blood pressure while standing, and associated lightheadedness), tinnitus (ringing in the ears), and photosensitivity (sensitivity to light). Potentially serious side effects include electrolyte abnormalities, low blood pressure, and hearing loss. It is recommended that serum electrolytes (especially potassium), serum CO2, creatinine, BUN levels, and liver and kidney functioning be monitored in patients taking furosemide. It is also recommended to be alert for the occurrence of any potential blood dyscrasias. Furosemide works by decreasing the reabsorption of sodium by the kidneys. Common side effects of furosemide injection include hypokalemia (low potassium level), hypotension (low blood pressure), and dizziness. Furosemide was patented in 1959 and approved for medical use in 1964. It is on the World Health Organization's List of Essential Medicines. In the United States, it is available as a generic medication. In 2023, it was the 29th most commonly prescribed medication in the United States, with more than 19 million prescriptions. In 2020/21 it was the twentieth most prescribed medication in En...

Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

40 shown
Contrast-Induced Acute Kidney Injury Prevention in Acute Heart FailureNCT07550790 · 2026-07-01
RECRUITING
Diuretics vs. Afterload Reduction for Treatment of HeartLogic AlertsNCT06218199 · 2021-07-08
RECRUITING
ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.NCT07737964 · 2026-10-01
NOT_YET_RECRUITING
Furosemide vs Placebo in Severe Preeclampsia PostpartumNCT07648251 · 2026-06-15
NOT_YET_RECRUITING
SURE-HF: Urinary Sodium-Guided Diuretic Therapy in Heart FailureNCT07631780 · 2026-06-01
NOT_YET_RECRUITING
A Study of Ultra High Dose Diuretics to Treat Heart FailureNCT06036914 · 2023-11-27
COMPLETED
Diuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic ResistanceNCT05986773 · 2023-10-10
TERMINATED
A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver CirrhosisNCT05741372 · 2023-09-07
COMPLETED
Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate CancerNCT05779943 · 2023-04-27
ACTIVE_NOT_RECRUITING
The Addition of Inhaled Furosemide to Standard Treatment of COPD ExacerbationNCT05769738 · 2023-03-01
UNKNOWN
Lasix for the Prevention of De Novo Postpartum HypertensionNCT04752475 · 2021-10-20
COMPLETED
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986308 in Healthy ParticipantsNCT04763226 · 2021-04-14
COMPLETED
Efficacy and Safety Evaluation of Tolvaptan in the Treatment of Patients With RHF Caused by PAHNCT05569655 · 2021-04-06
UNKNOWN
Torsemide Comparison With Furosemide for Management of Patients With Stable Heart FailureNCT05093621 · 2021-02-08
COMPLETED
Furosemide vs. Placebo for Severe Antepartum HypertensionNCT04615624 · 2021-01-04
COMPLETED
Postpartum Management of Gestational Hypertensive Disorders Using FurosemideNCT04343235 · 2020-05-01
TERMINATED
A Trial to Study BAY1753011 in Patients With Congestive Heart FailureNCT03901729 · 2019-05-29
COMPLETED
Protocol of Diuretics Use in Congestive Therapy in Heart FailureNCT03892148 · 2019-05-17
COMPLETED
An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop DiureticNCT03730961 · 2019-01-17
COMPLETED
TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart FailureNCT03296813 · 2018-07-11
COMPLETED
Pharmacokinetics, Safety and Tolerability of Concurrent Doses of BIA 5-1058 and FurosemideNCT07173738 · 2018-06-11
COMPLETED
Intravenous Vasodilator vs. Inotropic Therapy in Patients With Heart FailureNCT02767024 · 2018-05-01
WITHDRAWN
Effects of Furosemide Plus Small HSS in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)NCT04628325 · 2017-03-01
COMPLETED
A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy SubjectsNCT03010475 · 2017-01-05
COMPLETED
Short-term Efficacy of Furosemide, Isosorbide Dinitrate and Their Combination in ADHFNCT02649998 · 2017-01-01
WITHDRAWN
Subcutaneous Furosemide in Acute Decompensated Heart Failure PilotNCT02877095 · 2016-12-19
COMPLETED
Prevention of Severe Postpartum HypertensionNCT02450773 · 2015-08-01
WITHDRAWN
Effect of Furosemide Withdraw in Stable Chronic Heart Failure OutpatientsNCT02689180 · 2015-05-01
UNKNOWN
Aquaresis Utility for Hyponatremic Acute Heart Failure StudyNCT02183792 · 2014-12-01
COMPLETED
Aerosol Inhalation Treatment for Dyspnea - PatientsNCT02524054 · 2014-11-01
COMPLETED
Diuretics for Postpartum High Blood Pressure in PreeclampsiaNCT02163655 · 2014-06-20
COMPLETED
A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011)NCT01558674 · 2014-05-23
TERMINATED
Combination Diuretic Therapy for Acute Decompensated Heart FailureNCT05840536 · 2014-05-01
WITHDRAWN
A Prospective, Single-center, Randomized, Controlled, Open-label, Pilot Study to Compare the Effectiveness and Safety of DIuretics Add-On Strategy in Acute Decompensated Heart Failure Patients (DIOS II)NCT02047422 · 2014-01-01
WITHDRAWN
The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart FailureNCT01942109 · 2013-09-01
UNKNOWN
Diuretics and Dopamine in Heart Failure With Preserved Ejection FractionNCT01901809 · 2013-08-01
COMPLETED
Effectiveness of a Diuretic Algorithm in Clinical Stability in Heart Failure PatientsNCT02068937 · 2013-05-01
COMPLETED
Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid OverloadNCT01508260 · 2013-03-01
WITHDRAWN
OUTpatient Intravenous LASix Trial in Reducing Hospitalization for Acute Decompensated Heart FailureNCT04691687 · 2012-05-01
COMPLETED
Troponin I Release After High Diuretic DosesNCT01419132 · 2011-08-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.